ClearPoint Neuro Inc vs Lockheed Martin Corporation — how do they compare? ClearPoint Neuro Inc trades at $14.86 (market cap $454.21M), while Lockheed Martin Corporation trades at $596.99 (market cap $137.96B). The key difference: Lockheed Martin Corporation is far larger — about 303.7× ClearPoint Neuro Inc's market cap, and Lockheed Martin Corporation pays a 2.31% dividend while ClearPoint Neuro Inc pays none. Which is the better fit depends on your goals.
| CLPT | LMT | |
|---|---|---|
Market Cap | $454.21M | $137.96B |
Sector | Health | Industrials |
52-Week High | $29.60 | $676.70 |
52-Week Low | $8.66 | $431.56 |
Enterprise Value | $488.79M | $154.71B |
Dividend Yield | — | 2.31% |
Trailing returns across standard periods
Latest headlines on both assets
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →Lockheed Martin is the largest defense contractor globally and has dominated the Western market for high-end fighter aircraft since the F-35 program was awarded in 2001. Lockheed's largest segment is aeronautics, which is dominated by the massive F-35 program. Lockheed's remaining segments are rotary and mission systems, which is mainly the Sikorsky helicopter business.
Read more on LMT →